Evaluation of Adult Onset Still Disease Classification Criteria and Differential Diagnosis at Eighteen Months of Follow-up
AOSD-DIF
1 other identifier
observational
312
0 countries
N/A
Brief Summary
Adult Onset Still Disease (AOSD) is an acquired inflammatory disease of unknown etiology, presenting with non specific symptoms. Its diagnosis rely on sets of criteria, i.e. Fautrel Criteria and Yamaguchi Criteria. However, differential diagnosis might appear during follow-up of patients. The aim of this study is to assess diagnostic performance of Fautral and Yamaguchi Criteria after 18 months of follow-up, and to describe differential diagnosis appearing during follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2021
CompletedFirst Submitted
Initial submission to the registry
February 8, 2021
CompletedFirst Posted
Study publicly available on registry
February 11, 2021
CompletedFebruary 11, 2021
February 1, 2021
10.6 years
February 8, 2021
February 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
diagnosis performance of Yamaguchi and Fautrel criteria at 18 months of follow-up
Sensitivity, Specificity, positive predictive value, negative predictive value
after 18 months of follow-up
Secondary Outcomes (2)
description of differential diagnosis mimicking adult onset still disease
after 18 months of follow-up
identifying factors associated with the occurence of a differential diagnosis during follow-up
after 18 months of follow-up
Interventions
Eligibility Criteria
Adult patients with suspected adult onset still disease with at least 18 months of follow-up.
You may qualify if:
- adults
- with glycosylated ferritin dosage for suspected adult onset still disease
- with at least 18 month of follow-up
You may not qualify if:
- known infectious disease
- known cancer
- known active connective tissue disease or vasculitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2021
First Posted
February 11, 2021
Study Start
July 15, 2010
Primary Completion
February 1, 2021
Study Completion
February 1, 2021
Last Updated
February 11, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share